SCHEMBL7972891

SCHEMBL7972891

OCC1CCN(C(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL3 Q96JM7 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
KMT2A Q03164 3/20 0.55
MEN1 O00255 2/20 0.55
OPRM1 P35372 7/20 0.53
OPRK1 P41145 5/20 0.53
OPRL1 P41146 5/20 0.53
ALDH1A1 P00352 1/20 0.51
OPRD1 P41143 5/20 0.50
CHRM2 P08172 1/20 0.50
CHRM4 P08173 1/20 0.50
CHRM5 P08912 1/20 0.50
ADRA2A P08913 1/20 0.50
ADORA3 P0DMS8 1/20 0.50
CYP2D6 P10635 1/20 0.50
CHRM1 P11229 1/20 0.50
CHRM3 P20309 1/20 0.50
DRD1 P21728 1/20 0.50
ADRA1D P25100 1/20 0.50
HTR2A P28223 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8473380 0.86 L3MBTL3 (0.53) L3MBTL3L3MBTL1KMT2AMEN1OPRM1
SCHEMBL6778069 0.83 L3MBTL3 (0.50) L3MBTL3L3MBTL1KMT2AMEN1OPRM1
SCHEMBL6773183 0.83 CYP2D6 (0.61) OPRM1OPRK1OPRL1ALDH1A1OPRD1
SCHEMBL5390527 0.82 L3MBTL3 (0.49) L3MBTL3L3MBTL1KMT2AMEN1OPRM1
SCHEMBL8472991 0.82 L3MBTL3 (0.56) L3MBTL3L3MBTL1KMT2AMEN1OPRM1
SCHEMBL3458578 0.82 L3MBTL3 (0.56) L3MBTL3L3MBTL1KMT2AMEN1OPRM1
SCHEMBL8473371 0.82 L3MBTL3 (0.56) L3MBTL3L3MBTL1KMT2AMEN1OPRM1
SCHEMBL13597004 0.82 L3MBTL1 (0.56) L3MBTL3L3MBTL1KMT2AMEN1OPRM1
SCHEMBL9063533 0.82 MEN1 (0.55) L3MBTL3L3MBTL1KMT2AMEN1OPRM1
SCHEMBL72670 0.81 MEN1 (0.48) KMT2AMEN1OPRM1OPRK1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104718188-B The benzamides of N- substitutions and its purposes in treating pain 基因泰克公司 2018-08-21 CN disclosed
EP-2855428-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN Genentech, Inc. (US) 2015-04-08 EP disclosed
US-8952169-B2 N-substituted benzamides and methods of use thereof XENON PHARMACEUTICALS INC. (CA) 2015-02-10 US disclosed
US-8952169-B2 N-substituted benzamides and methods of use thereof XENON PHARMACEUTICALS INC. (CA) 2015-02-10 US disclosed
WO-2013177224-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN GENENTECH, INC. (US) 2013-11-28 WO disclosed
US-6235731-B1 REDUCING BLOOD LIPIDS, SUGARS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-22 US disclosed
EP-0915888-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS Takeda Chemical Industries, Ltd. (JP) 1999-05-19 EP disclosed
US-5872115-A COMPOUNDS FOR TREATMENT OF HYPERCHOLESTEROLEMIA, ISCHEMIC HEART DISEASE, CEREBROVASCULAR DISEASE OR ATHEROSCLEROSIS GRELAN PHARMACEUTICAL CO. LTD. (JP) 1999-02-16 US disclosed
WO-1997040051-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-10-30 WO disclosed
EP-0742208-A1 2-Ureido-benzamide derivatives GRELAN PHARMACEUTICAL CO., LTD. (JP) 1996-11-13 EP disclosed